Eikon Therapeutics Stock
Eikon Therapeutics is a biotechnology company focused on pioneering new methods of drug discovery through advanced imaging techniques. Eikon aims to revolutionize the understanding of protein dynamics and their implications for therapeutic development.
Sign up for SecondMarket™ to view the market and buy or sell Eikon Therapeutics Stock
Buy + SellEikon Therapeutics Funding
Sign up to gain insights into Eikon Therapeutics funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the Data| Date | Financing Round | Amount | Price per share* | Valuation* |
|---|---|---|---|---|
| May 16, 2023 | Series B | 140.76M | ||
| Jan 03, 2022 | Series B | 17.76M | ||
| Dec 03, 2021 | Series A | 500.00M | ||
| May 04, 2021 | Series A | 102.54M |
See Eikon Therapeutics Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Eikon Therapeutics Stock Valuation + Share Prices
View real-time Tape D™ data on Eikon Therapeutics stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.
Get Started
Eikon Therapeutics Management Team
CFO
W. Bradley Yale
CEO
Sidharth Malik
CSO
Dr. Catherine Feuillet
Co-Founder, COO, Director
Jamison Glenn
Director
Christopher Gabrieli
Chief Marketing Officer
Elizabeth Egan
Co-founder, CEO, Director
Tim Zheng
Director
Robert R. Schmidt
Director
Julie Anne Smith
Chief People Officer
Shobana Kailash
COO
Jeremy Delinsky
Chief Marketing Officer
Josh Harbert
Co-Founder, CTO, Director
Jonathan Perichon
Chief Revenue Officer
Adrian Agostini
Director
James Tannanbaum
Chief Scientific Officer
Dan Anderson
Chief Financial Officer
Alfred Bowie
Chief People Officer
Barbara Howes
Co-founder
Xavier Darzacq
Co-founder
Robert Tjian
Chief Technical Officer
Russ Berman
Director
Kenneth Frazier
Co-Founder
Joel Webber
Chief Business Officer
Benjamin Thorner
Director
Dror Berman
Chief Medical Officer
Roy Baynes
Director
Deborah Winshel
Co-founder
Eric Betzig
Chief Information Officer
Ashish Kheterpal
President, Director
Leon Chen
Chief Customer Officer
Inder Sidhu
CEO, Director
Roger Perlmutter
Director
Adam Goulburn
Director
Josh Wolfe
Director
Robin Washington
Director
Jishnu Bhattacharjee
Eikon Therapeutics Major Investors
Column Group
UC Investments (UCOP)
Horizon Ventures
E15 VC
AME Cloud Ventures LLC
Hartford HealthCare Endowment
T. Rowe Price Associates, Inc.
T. Rowe Price Associates, Inc.
Lux Capital
StepStone Group LLC
Harel Insurance Investements & Financial Services Ltd.
Foresite Capital
Innovation Endeavors LLC
General Catalyst Partners LLC
Schroders PLC
Canada Pension Plan Investment Board (CPPIB)
Soros Fund Management, LLC
Soros Fund Management, LLC
Abu Dhabi Investment Authority (ADIA)
EcoR1 Capital
Learn More About Eikon Therapeutics Stock
Buy Eikon Therapeutics Stock
01Sell Eikon Therapeutics Stock
02Eikon Therapeutics Stock Price
03Eikon Therapeutics Stock Ticker Symbol
04Criteria to Sell Eikon Therapeutics Stock
05Criteria to Buy or Invest in Eikon Therapeutics Stock
06Eikon Therapeutics Stock Settlement
07Eikon Therapeutics IPO
08*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.
Sign up for SecondMarket™ to view the market and buy or sell Eikon Therapeutics Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.
